Dr Gerd Sutter | Full Professor And Chair For Virology, Director, Department Of Veterinary Sciences
Lmu Munich | Germany

Dr Gerd Sutter, Full Professor And Chair For Virology, Director, Department Of Veterinary Sciences, Lmu Munich

Gerd Sutter is Professor and Chair of Virology in the Department of Veterinary Sciences of which he is the Director at the Ludwig-Maximilians Universität München (LMU Munich), Germany.
Prof. Gerd Sutter´s primary research fields include: Poxvirus infections, and mechanisms of (pox-)viral modulation of the host immune system including evasion of innate and adaptive responses to infection, and vaccine development with emphasis on vector vaccines based on Modified Vaccinia virus Ankara (MVA) for prevention of zoonotic and emerging virus infections, e.g. avian influenza, Middle East respiratory syndrome (MERS) and West Nile fever.
Prof. Gerd Sutter obtained his doctoral degree (Dr. med. vet., 1990) for his work on the genetics of vaccinia virus Ankara at LMU Munich. He pursued his training with a post-doctoral position in the laboratory of Bernard Moss at the National Institute of Health, USA (1990-1993), where he developed Modified Vaccinia virus Ankara (MVA) as an expression vector and established the use of first recombinant MVA vaccines. In 1994, he returned to Germany and continued working with poxviruses and MVA vaccines leading his own research group in the Institute of Molecular Virology at the Helmholtz Zentrum Munich. In 2003, Professor Sutter joined the Paul-Ehrlich-Institut in Langen, the Federal Institute for Vaccines and Biomedicines in Germany, to serve as Professor and Director of the Division of Virology. In 2009, he moved back to LMU Munich earning the position as Full Professor and the Chair for Virology.
In addition to his responsibilities at LMU Munich, Prof. Gerd Sutter is a member of several scientific advisory boards and review boards relating to his expertise in virology and vaccine development. He is a reviewer, for the German Research Foundation (DFG), the Federal Ministry of Research and Education of Germany, the National Institute of Allergy and Infectious Diseases (NIAID-NIH) in the USA, the Medical Research Council & the Wellcome Trust in UK, INSERM-INRA in France. Since 2012, he has been a Principal Investigator for the German Center for Infection Research (DZIF).


Oct 31st Day 3 @ 11:20

MERS prevention – developing a candidate vaccine for humans and camels

last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates